Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
COREGO: drug–drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trials
F Rethouze, Severine Risbourg, Camille Schiffler, Sylvie Chabaud, Antoine De Courreges, Marie‐Cécile Le Deley, Jean Yves Blay, Frédéric Feutry, Marta Jimenez, Marie Vanseymortier, Nicolas Penel, Florence Duffaud, Loïc Lebellec (2025). COREGO: drug–drug interaction analysis on the efficacy and safety of regorafenib in patients with a sarcoma: pooled analysis of the data from the REGOSARC and REGOBONE trials. , 10(6), DOI: https://doi.org/10.1016/j.esmoop.2025.105117.
Article25 days ago216eP MegaMOST - A multicenter, open-label, molecularly selected bayesian phase II platform trial in advanced or metastatic solid tumors: Final analysis of the trametinib cohort
Olivier Trédan, E.B. Saada, Cécile Dalban, Sophie Cousin, A. Le Cesne, A. Italiano, François Bertucci, C.A. Gomez-Roca, Lauriane Eberst, I. L. Ray-Coquard, Loïc Verlingue, P. Cassier, Valéry Attignon, Sylvie Chabaud, Romaine Mayet, E. Cauquil, G. Garin, David Pérol, Jean Yves Blay (2025). 216eP MegaMOST - A multicenter, open-label, molecularly selected bayesian phase II platform trial in advanced or metastatic solid tumors: Final analysis of the trametinib cohort. , 36, DOI: https://doi.org/10.1016/j.annonc.2025.08.648.
Article25 days agoReply to: Critical evaluation of the ProfiLER-02 study design and outcomes
Olivier Trédan, Marie-Sarah Cabrillac, Sylvie Chabaud, Gwenaëlle Garin, David Pérol, Jean Yves Blay (2025). Reply to: Critical evaluation of the ProfiLER-02 study design and outcomes. , 31(10), DOI: https://doi.org/10.1038/s41591-025-03960-9.
Letter25 days agoBroad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial
Olivier Trédan, Damien Pouessel, Nicolas Penel, Sylvie Chabaud, Carlos Gomez‐Roca, Jean-Pierre Delord, Diane Pannier, Mehdi Brahmi, Michel Fabbro, Marie-Eve Garcia, Delphine Larrieu‐Ciron, Isabelle Ray‐Coquard, Marie Viala, Antoîne Italiano, Diégo Tosi, Philippe A. Cassier, Armelle Dufresne, Valéry Attignon, Sandrine Boyault, Isabelle Treilleux, Alain Viari, David Pérol, Jean Yves Blay (2025). Broad versus limited gene panels to guide treatment in patients with advanced solid tumors: a randomized controlled trial. , 31(5), DOI: https://doi.org/10.1038/s41591-025-03613-x.
Article25 days agoThe French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST
Loïc Verlingue, Marine Desevre, M. Polito, Gwenaëlle Garin, Christine Rodriguez, Qing Wang, Olivier Trédan, David Pérol, Isabelle Ray‐Coquard, Sylvie Chabaud, Jean Yves Blay (2024). The French multicentric molecular analysis platforms and personalized medicine trials MOST, MOST Plus and MEGAMOST. , 63, DOI: https://doi.org/10.2340/1651-226x.2024.32745.
Article25 days ago